Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New trends in breast conservation therapy.

Lisa A Newman1, Tara A Washington

  • 1Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0932, USA. lanewman@umich.edu

The Surgical Clinics of North America
|July 24, 2003
PubMed
Summary

Breast conservation therapy offers survival comparable to mastectomy for early-stage invasive breast cancer. Advances in surgical techniques and treatments improve success rates and expand eligibility for breast-conserving surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lobular breast cancer statistics, 2025.

Cancer·2025
Same author

Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS).

Annals of surgical oncology·2025
Same author

Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc analysis of the ECOG-ACRIN 1131 clinical trial.

Breast cancer research and treatment·2025
Same author

Hormone Receptor Status of Second Breast Cancers in Women With Triple-Negative Breast Cancer.

JAMA surgery·2025
Same author

Breast cancer statistics 2024.

CA: a cancer journal for clinicians·2024
Same author

Importance of Cooperation Between Cooperative Group Clinical Trialists.

JAMA surgery·2024

Area of Science:

  • Oncology
  • Surgical Oncology

Background:

  • Breast conservation therapy (BCT) is a viable alternative to mastectomy for early-stage invasive breast cancer, offering equivalent survival rates.
  • Minimizing local recurrence is crucial for successful BCT outcomes, necessitating careful patient selection and surgical expertise.

Purpose of the Study:

  • To review the evolution and current status of breast conservation therapy for early-stage invasive breast cancer.
  • To identify risk factors for local recurrence and discuss strategies to improve BCT success rates.
  • To explore emerging trends and future innovations in BCT.

Main Methods:

  • Review of extensive studies on BCT over the past 15 years.
  • Analysis of risk factors for local recurrence and patient selection criteria.

Related Experiment Videos

  • Evaluation of recent trends including induction chemotherapy, advanced imaging, intraoperative margin evaluation, and brachytherapy.

    • Main Results:

    • BCT provides survival equivalent to mastectomy for early-stage invasive breast cancer.
    • Modified BCT approaches can safely manage cases previously ineligible for lumpectomy.
    • Technological advancements like induction chemotherapy, MRI, ultrasound, and touch-prep cytology enhance BCT success.

    Conclusions:

    • Breast conservation therapy is a safe and effective treatment for early-stage invasive breast cancer.
    • Ongoing innovations in surgical techniques, adjuvant therapies, and diagnostic tools are expanding BCT applicability.
    • Aggressive management of local recurrences after BCT can lead to favorable long-term survival outcomes.